Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -0.6491M
March 31, 2026 -0.7233M
December 31, 2025 -0.2561M
September 30, 2025 0.0782M
June 30, 2025 -0.5942M
March 31, 2025 -1.873M
December 31, 2024 -0.7868M
September 30, 2024 -0.3336M
June 30, 2024 -0.976M
March 31, 2024 -0.2142M
December 31, 2023 -0.1198M
September 30, 2023 -1.373M
June 30, 2023 -0.6298M
March 31, 2023 0.5093M
December 31, 2022 -0.1826M
September 30, 2022 0.1997M
June 30, 2022 -0.0534M
March 31, 2022 -0.1648M
December 31, 2021 -0.5588M
September 30, 2021 -0.1823M
June 30, 2021 0.122M
March 31, 2021 0.142M
December 31, 2020 -0.0448M
September 30, 2020 -0.1726M
June 30, 2020 -0.5081M
Date Value
March 31, 2020 0.3849M
December 31, 2019 -0.4706M
September 30, 2019 0.0013M
June 30, 2019 -0.0776M
March 31, 2019 -0.3766M
December 31, 2018 -0.5711M
September 30, 2018 -0.0064M
June 30, 2018 0.2074M
March 31, 2018 -0.1748M
December 31, 2017 0.1996M
September 30, 2017 -0.1316M
June 30, 2017 -0.0355M
March 31, 2017 -0.3525M
December 31, 2016 -0.4372M
September 30, 2016 0.1578M
June 30, 2016 -0.1261M
March 31, 2016 -0.2253M
December 31, 2015 -0.3998M
September 30, 2015 -0.1251M
June 30, 2015 -0.049M
March 31, 2015 -0.0646M
December 31, 2014 -0.069M
September 30, 2014 -0.5912M
June 30, 2014 -0.2172M
March 31, 2014 -0.2192M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
RxSight, Inc. -9.538M
Abbott Laboratories 2.488B
Align Technology, Inc. 192.76M
AngioDynamics, Inc. -15.33M
Accuray, Inc. 2.427M